# Zenith Vascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zenith-vascular

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.zenithmedtech.cn
- Total disclosed funding: $15M
- Latest round: Series B (Jul 5, 2021)
- Investors on record: 8

## About

Established in 2018 and based in Suzhou, China, Zenith Vascular operates as a medical device company dedicated to providing vascular interventional devices. It acquired certifications such as GMP workshop certification, ISO13485 system certification, and high-tech enterprise certification. The company has obtained 43 patents, including 13 invention patents. In December 2024, it closed a round of venture funding.

The company mainly provides vascular interventional devices. It provides products and solutions in four areas, which are AIS (Acute Ischemic Stroke), access product solutions, carotid artery stenosis (CAS), and peripheral vascular diseases (PVD). For AIS, the company provides thrombus aspiration catheters, delivery-assisted microcatheters, distal access catheters, microcatheters, microguidewires, and balloon dilatation catheters. For CAS, Zenith Vascular provides carotid stents, distal protectors, and carotid dilatation balloons. For PVD, it provides peripheral thrombus aspiration catheters and venous stent systems.

The company generates revenue by providing vascular interventional devices such as thrombus aspiration catheters, carotid stents, and peripheral thrombus aspiration catheters.

## Funding rounds

- Series B, Jul 5, 2021, $15M — Qianrong Capital, Insight Capital
- Series A, Aug 31, 2020 — Lotus Lake Capital, Dingxin Capital, NVA Capital
- Series A, Jan 23, 2019 — NLVC, Oriza Holdings, Ming Bioventures
- Angel, Nov 9, 2018 — Oriza Holdings, Ming Bioventures

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Angel, Series A
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Angel, Series A
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series A
- Dingxin Capital — Series A
- NVA Capital (https://capitalatlas.ai/funds/nva-capital) — Series A
- Qianrong Capital (https://capitalatlas.ai/funds/qianrong-capital) — Series B
- Insight Capital — Series B